First-of-its-kind partnership between Aidoc and NVIDIA MONAI takes models from lab to scaled clinical use; new Quibim collaboration adds best-in-class Prostate MRI AI NEW YORK, /PRNewswire/ -- Aidoc, ...

(Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a ...

The Trump administration is quietly testing an artificial intelligence system that will help decide which Medicare patients ...

Imagion Biosystems is on track for IND submission this month and a Phase 2 clinical trial in the US early ... Read More The ...

Artificial Intelligence (AI) is increasingly transforming healthcare. Hospitals and health systems are exploring AI to ...

At RSNA 2025, RapidAI will be featured in the AWS booth, showcasing the Rapid Edge Cloud™, the market's only cloud-native platform with on-prem capabilities that ensure continuous, secure operation in ...

Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

Ongoing Phase 1b/2 Trial of the Allosteric MEK1/2 Inhibitor REC-4881 as Monotherapy (FAP): Updated Safety and Efficacy Najat Khan, Ph.D ., Chief R&D and Chief Commercial Officer and incoming CEO and ...

Recent advancements in artificial intelligence (AI) have revolutionized the application of electrocardiography (ECG) in ...

AI is not limited to diagnostics or imaging. It also plays a transformative role in biomedical research, computational modeling, genomics and drug development. The authors highlight how ...

When ophthalmologist Emily Cole, MD, steps into the neonatal intensive care unit (NICU) at Children's Hospital Colorado to ...

Machine learning is increasingly recognized as a pivotal tool in the evolution of cardiovascular medicine, promising to ...